Changes in invasive pneumococcal disease serotypes in a regional area of Australia following three years of 7vPCV introduction
Author(s) -
Tove Fitzgerald,
Peter Massey,
Fakhrul Islam
Publication year - 2012
Publication title -
western pacific surveillance response journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.515
H-Index - 16
eISSN - 2094-7313
pISSN - 2094-7321
DOI - 10.5365/wpsar.2011.2.4.009
Subject(s) - serotype , pneumococcal conjugate vaccine , medicine , population , vaccination , confidence interval , streptococcus pneumoniae , pneumococcal disease , pneumococcal infections , demography , conjugate vaccine , pneumococcal vaccine , pediatrics , virology , biology , immunology , environmental health , immunization , microbiology and biotechnology , antibiotics , sociology , antigen
Invasive pneumococcal disease (IPD) is a serious bacterial disease. Vaccination can prevent disease for many of the current serotypes. The aim of this investigation was to describe the notification rates of IPD in a regional area of Australia, explore changes in rates since the introduction of the population vaccine programmes in 2005 and to describe changes in the distribution of serotypes in relation to the available vaccines after three years.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom